AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL AAPG

NasdaqMid CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 8 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$574.12M

Quarter to Dec 31

Net income

$-1.24B

Quarter to Dec 31

Free cash flow

$-1.20B

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$263.5K total
Point72 Asset Management, L.P.
$243.0K-13.8%
MORGAN STANLEY
$16.1K+84.5%
WELLS FARGO & COMPANY/MN
$3.5KNew
EverSource Wealth Advisors, LLC
$421-66.2%
UBS Group AG
$263-87.9%
BlackRock, Inc.
$105New
Caitong International Asset Management Co., Ltd
$18New
ROYAL BANK OF CANADA
$00.0%
See all 8 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Loading ratio trend…

AAPG key financials by period

Reported revenue, net income and operating margin by fiscal year, from ASCENTAGE PHARMA GROUP INTERNATIONAL's annual filings on SEC EDGAR.

ASCENTAGE PHARMA GROUP INTERNATIONAL reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$574.1M$-1.2B—
FY 2024$980.6M$-405.4M-40.3%
FY 2023$222.0M$-925.6M—
FY 2022$209.7M$-882.9M—
Source: AAPG filings on SEC EDGAR →

AAPG insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG): stock profile, AI score and financials

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. AAPG is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 8 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), ASCENTAGE PHARMA GROUP INTERNATIONAL reports quarterly revenue of $574.1M, net income of $-1.2B, free cash flow of $-1.2B. Top institutional holders of AAPG by reported 13-F value include Point72 Asset Management, L.P., MORGAN STANLEY, WELLS FARGO & COMPANY, based on the most recent SEC filings. AAPG trades on the Nasdaq exchange and files with the SEC under CIK 2023311. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AAPG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ASCENTAGE PHARMA GROUP INTERNATIONAL directly from SEC EDGAR.

SEC EDGAR: CIK 2023311 →